Mobile Logo in White

Events

Texas Pediatric Cancer Drug Testing Core Seminar Series


The Texas Pediatric Cancer Drug Testing Core (TPC-DTC) will be hosting the virtual seminar series for those interested in preclinical evaluation of novel agents in xenograft mouse models of pediatric cancer.
The objective of the CPRIT-supported TPC-DTC is to provide reproducible high-quality in vivo data to guide pediatric clinical development of novel agents and combinations.
The TPC-DTC provides access to~400 PDX/CDX models of pediatric cancers as a resource.

Save the Dates for the Talks by:

2025-2026

Paul Northcott, PhD

Date: September 9, 2025

Paul Northcott, PhD

St. Jude Children’s Research Hospital

Olena Vaske, PhD

Date: October 14, 2025

Olena Vaske, PhD

UC Santa Cruz

John Powers, PhD

Date: November 11, 2025

John Powers, PhD

UT Austin

Raushan Kurmasheva, PhD

Date: January 13, 2026

Raushan Kurmasheva, PhD

UT Health SA

Siyuan Zheng, PhD

Date: January 13, 2026

Siyuan Zheng, PhD

UT Health SA

John Kalapurakal, MD

Date: February 10, 2026

John Kalapurakal, MD

Northwestern

Zoom link will be provided closer to the seminar start date in September 2025
(Seminars to be held on 2nd Tuesdays of the month @ 11am-12pm)